Literature DB >> 19838533

Brainstem cavernous malformations: a review with two case reports.

Adolfo Ramírez-Zamora1, José Biller.   

Abstract

Central nervous system (CNS) cavernous malformations (CMs) are developmental malformations of the vascular bed with a highly variable clinical course due to their dynamic nature. We present one case of 'de novo' brainstem cavernous malformation after radiation therapy adding to the increasing number of reported cases in the medical literature, and the case of a pregnant patient with symptomatic intracranial hemorrhage related to brainstem CMs to illustrate the complex nature in management of these patients, followed by a review of clinical and radiographic characteristics. CMs account for 8-15% of all intracranial and intraspinal vascular malformations. Although traditionally thought to be congenital in origin, CMs may present as acquired lesions particularly after intracranial radiation therapy. Clinical manifestations are protean and surgical treatment should be considered for patients with progressive neurologic deficits.

Entities:  

Mesh:

Year:  2009        PMID: 19838533     DOI: 10.1590/s0004-282x2009000500030

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Intraspinal cavernous bleeding during early pregnancy.

Authors:  Kaweh Pars; Niklas Garde; Josef Conzen; Refik Pul; Reinhard Dengler; Martin Stangel; Thomas Skripuletz; Corinna Trebst
Journal:  J Neurol       Date:  2016-08-03       Impact factor: 4.849

2.  PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.

Authors:  Aileen A Ren; Daniel A Snellings; Yourong S Su; Courtney C Hong; Marco Castro; Alan T Tang; Matthew R Detter; Nicholas Hobson; Romuald Girard; Sharbel Romanos; Rhonda Lightle; Thomas Moore; Robert Shenkar; Christian Benavides; M Makenzie Beaman; Helge Müller-Fielitz; Mei Chen; Patricia Mericko; Jisheng Yang; Derek C Sung; Michael T Lawton; J Michael Ruppert; Markus Schwaninger; Jakob Körbelin; Michael Potente; Issam A Awad; Douglas A Marchuk; Mark L Kahn
Journal:  Nature       Date:  2021-04-28       Impact factor: 49.962

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.